Literature DB >> 10653070

Remission of facial and scalp hyperhidrosis with clonidine hydrochloride and topical aluminum chloride.

E M Torch1.   

Abstract

Axillary and palmar hyperhidrosis are featured prominently in the literature, but no previous studies have detailed a treatment regimen for specific excessive localized sweating of the face and scalp. In this report, a patient was treated for this condition with a combination of clonidine hydrochloride (0.3 mg to 0.4 mg, with 0.25 mg to be taken at bedtime, to prevent daytime sedation) [corrected] and a topical solution of 20% aluminum chloride in anhydrous ethyl alcohol (Drysol). Over a period of 2 or 3 weeks, the patient achieved a complete remission of symptoms, while having only mild side effects. The treatment regimen also had the added advantage of lowering generalized anxiety.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653070

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.

Authors:  William P Cheshire; Robert D Fealey
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 2.  Use of Systemic Therapies to Manage Focal Hyperhidrosis.

Authors:  Dee Anna Glaser; Katherine Glaser
Journal:  Mo Med       Date:  2015 Jul-Aug

Review 3.  Current and Emerging Medical Therapies for Primary Hyperhidrosis.

Authors:  Daniel A Grabell; Adelaide A Hebert
Journal:  Dermatol Ther (Heidelb)       Date:  2016-10-27

4.  Reduction of focal sweating by lipid nanoparticle-delivered myricetin.

Authors:  Choongjin Ban; Joon-Bum Park; Sora Cho; Hye Rin Kim; Yong Joon Kim; Young Jin Choi; Woo-Jae Chung; Dae-Hyuk Kweon
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.